Qiagen N.V. (QGEN)
NYSE: QGEN · Real-Time Price · USD
46.80
-0.16 (-0.34%)
At close: Oct 7, 2025, 4:00 PM EDT
46.71
-0.09 (-0.19%)
Pre-market: Oct 8, 2025, 8:00 AM EDT
Qiagen Employees
Qiagen had 5,967 employees as of December 31, 2023. The number of employees decreased by 211 or -3.42% compared to the previous year.
Employees
5,967
Change (1Y)
-211
Growth (1Y)
-3.42%
Revenue / Employee
$341,892
Profits / Employee
$62,575
Market Cap
10.15B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 5,967 | -211 | -3.42% |
Dec 31, 2022 | 6,178 | 150 | 2.49% |
Dec 31, 2021 | 6,028 | 418 | 7.45% |
Dec 31, 2020 | 5,610 | 514 | 10.09% |
Dec 31, 2019 | 5,096 | 144 | 2.91% |
Dec 31, 2018 | 4,952 | 264 | 5.63% |
Dec 31, 2017 | 4,688 | 4 | 0.09% |
Dec 31, 2016 | 4,684 | 125 | 2.74% |
Dec 31, 2015 | 4,559 | 220 | 5.07% |
Dec 31, 2014 | 4,339 | 324 | 8.07% |
Dec 31, 2013 | 4,015 | 16 | 0.40% |
Dec 31, 2012 | 3,999 | 61 | 1.55% |
Dec 31, 2011 | 3,938 | 351 | 9.79% |
Dec 31, 2010 | 3,587 | 92 | 2.63% |
Dec 31, 2009 | 3,495 | 454 | 14.93% |
Dec 31, 2008 | 3,041 | 379 | 14.24% |
Dec 31, 2007 | 2,662 | 708 | 36.23% |
Dec 31, 2006 | 1,954 | 365 | 22.97% |
Dec 31, 2005 | 1,589 | 267 | 20.20% |
Dec 31, 2004 | 1,322 | -231 | -14.87% |
Dec 31, 2003 | 1,553 | -98 | -5.94% |
Dec 31, 2002 | 1,651 | 94 | 6.04% |
Dec 31, 2001 | 1,557 | 242 | 18.40% |
Dec 31, 2000 | 1,315 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
QGEN News
- 12 days ago - Qiagen N.V. (QGEN) Presents at Bank of America Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 27 days ago - QIAGEN Secures European CE-IVDR Certification for Full QIAstat-Dx Portfolio - Business Wire
- 27 days ago - Qiagen N.V. (QGEN) Presents At Baird Global Healthcare Conference 2025 Prepared Remarks Transcript - Seeking Alpha
- 4 weeks ago - Qiagen N.V. (QGEN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 5 weeks ago - QIAGEN Gains U.S. Clearance of Higher-Throughput QIAstat-Dx Rise, Expanding Patient Access to Rapid Syndromic Testing - Business Wire
- 5 weeks ago - QIAGEN N.V. Announces Conversion Price of New Net Share Settled Convertible Bonds - Business Wire
- 5 weeks ago - QIAGEN N.V. Announces Successful Placement of New Net Share Settled Convertible Bonds - Business Wire
- 5 weeks ago - QIAGEN N.V. Launches Non-US Offering of Net Share Settled Convertible Bonds - Business Wire